Hi there
This is excellent information, and the reason that I re-subscribed. I am
a wife of a TM'er in the UK, and wanted to find out if this drug was
suitable for people that have TM. In the UK the media never cover TM. Do
we know yet?
I only came back on line on Friday so I may have missed something
regarding this matter! Any information would be greatly received.
Many people helped me a great deal a couple of years ago, as I had so
many questions, and a husband unwilling to ask, and doctors in the UK in
the dark about TM. Thank you so much to those people.
I must say that one of the reasons I did not stay on the list was that
people said they would pray for me, which I found very upsetting and
also annoying. In the subject heading I had no idea before I read their
post that it would contain such statements, so I am not sure about the
advice given to Sandy? How do you know to delete it before you have read
it? And if you read it before deleting the damage is done.
I am an atheist and I would never think to mention it. Positive thoughts
can mean many things to many people, so why not just say that? Sandy and
Rob are so right when they say it's just not a place for politics or
religion. BUT if you mark the content in the subject heading and people
on the list think they might be offended they can DELETE!
Anyway this is just the opinion of a TM'ers wife from the UK! Please
take no notice of my ramblings if it gives offence!
Kind regards
Sally in the UK!
-----Original Message-----
From: Trudy OGILVIE [mailto:[EMAIL PROTECTED]
Sent: 25 October 2008 01:05
To: TMIC-LIST@eskimo.com
Subject: [TMIC] MS drug /maybe??
My daughter saw this article on Yahoo and sent it on to me. Very
interesting
since some of us have TM/MS I thought you might want to read it...
It's certainly an improvement over what's being going on with some of
the
TM'ers on this list..... :)
Frank..... welcome back!! you certainly arrived with an agenda!!! Now
read
this article tell us what you think and then have your martini...
There is always Hope! Trudy
- Researchers at the University of Cambridge said they have found that
alemtuzumab, a drug originally developed .
>
> LONDON (AFP) - Researchers at the University of Cambridge said
Thursday
they have found that a drug originally developed to treat leukaemia can
halt
and even reverse the debilitating effects of multiple sclerosis (MS).
>
> In trials, alemtuzumab reduced the number of attacks in sufferers and
also
helped them recover lost functions, apparently allowing damaged brain
tissue
to repair so that individuals were less disabled than at the start of
the
study.
>
> "The ability of an MS drug to promote brain repair is unprecedented,"
said
Dr Alasdair Coles, a lecturer at Cambridge university's department of
clinical neurosciences, who coordinated many aspects of the study.
>
> "We are witnessing a drug which, if given early enough, might
effectively
stop the advancement of the disease and also restore lost function by
promoting repair of the damaged brain tissue."
>
> The MS Society, Britain's largest support charity for those affected
by
the condition, said it was "delighted" at the trial's results, which
must be
followed up with more research before the drug can be licensed.
>
> "This is the first drug that has shown the potential to halt and even
reverse the debilitating effects of MS and this news will rightly bring
hope
to people living with the condition day in, day out," said head of
research
Lee Dunster.
>
> MS is an auto-immune disease that affects millions of people
worldwide,
including almost 100,000 in Britain and 400,000 in the United States.
>
> It is caused by the body's immune system attacking nerve fibres in the
central nervous system, and can lead to loss of sight and mobility,
depression, fatigue and cognitive problems. There is no cure, and few
effective treatments.
>
> In the trial, 334 patients diagnosed with early-stage
relapsing-remitting
MS who had not previously been treated were given alemtuzumab or
interferon
beta-1a, one of the most effective licensed therapies for similar MS
cases.
>
> After three years, alemtuzumab was found to reduce the number of
attacks
the patients suffered by 74 percent over the other treatment, and reduce
the
risk of sustained accumulation of disability by 71 percent over
interferon
beta-1a.
>
> Many individuals who took alemtuzumab also recovered some of their
lost
functions, becoming less disabled by the end, while the disabilities of
the
other patients worsened, the study in the New England Journal of
Medicine
said.
>
> Alastair Compston, professor of neurology and head of the clinical
neurosciences department at Cambridge, said alemtuzumab was the "most
promising" experimental drug for the treatment of MS.
>
> He expressed hope that further trials "will confirm that it can both
stabilise and allow some recovery of what had previously been assumed to
be
irreversible disabilities".
>
> Alemtuzumab was developed in Cambridge and has been licensed for the
treatment of chronic lymphocytic leukaemia.
>
>
_________________________________________________________________
You live life beyond your PC. So now Windows goes beyond your PC.
http://clk.atdmt.com/MRT/go/115298556/direct/01/
No virus found in this incoming message.
Checked by AVG - http://www.avg.com
Version: 8.0.175 / Virus Database: 270.8.3/1748 - Release Date:
10/26/2008
7:53 PM
No virus found in this incoming message.
Checked by AVG - http://www.avg.com
Version: 8.0.175 / Virus Database: 270.8.3/1748 - Release Date: 10/27/2008
7:57 AM
